The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes

Podobne zapisy

• Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study
  od: Araki, E., i wsp.
  Wydane: (2015)
• Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes
  od: Iwamoto, Noriyuki, i wsp.
  Wydane: (2017)
• Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
  od: Onishi, Yukiko, i wsp.
  Wydane: (2020)
• Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
  od: Suzuki, Shuichi, i wsp.
  Wydane: (2017)
• Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus
  od: Nakamura, Jiro, i wsp.
  Wydane: (2017)